Unilever Plc Overview
| Item | Detail |
|---|---|
| Entity profiled | Unilever PLC (parent of the Unilever Group) |
| Listing status | Public, listed (matches the type supplied) |
| Website | www.unilever.com |
| Country of incorporation | England and Wales (United Kingdom) |
| Former names / structure | Incorporated in 1894 as Lever Brothers Limited; later Unilever Limited, then Unilever PLC. From 1930 to November 2020 the Group operated a dual-parent structure (Unilever PLC in the UK and Unilever N.V. in the Netherlands); Unification under the single parent Unilever PLC completed on 29 November 2020 |
| Founding year | Unilever formed by the merger of Lever Brothers (UK, founded 1885) and Margarine Unie (Netherlands) in 1929, effective 1 January 1930 |
| Headquarters | 100 Victoria Embankment, London EC4Y 0DY, United Kingdom (Form 20-F 2025) |
| Stock exchanges and tickers | London Stock Exchange: ULVR; Euronext Amsterdam: UNA; New York Stock Exchange: UL (American Depositary Shares, one ADS = one ordinary share) |
| ISIN | Legacy ordinary-share ISIN GB00B10RZP78; market data sources show GB00BVZK7T90 following the December 2025 share consolidation (confirm with registrar) |
| CUSIP (ADS) | 904767704 (legacy) |
| SEC file number | 001-04546 (Form 20-F filer, large accelerated filer) |
| Fiscal year end | 31 December |
| Auditor | KPMG LLP (London); H1 2026 review report signed by Jonathan Downer, 27 July 2026 |
| Ordinary shares outstanding | 2,181,005,247 at 31 December 2025 (Form 20-F 2025); a further 30,703,780 shares were repurchased between 30 April and 5 June 2026 |
| Employees (latest) | c.96,000 (continuing operations, Form 20-F 2025) |
| Market capitalisation (current) | ≈ £100bn (≈ €115bn) — share price 4,664.5p on 25 September 2026 × c.2.15bn shares; eToro reported ≈ £101bn in the same period. Analyst-computed; not an official company figure |
| Credit ratings | S&P A+ / A-1 (outlook negative); Moody's A1 / P-1 (outlook stable) — company debt-investor page |
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Employees (approx., thousands) | 128 | 128 | 96 |
FY2023 and FY2024 figures are the c.128,000 headcount cited by Unilever and media at the launch of the productivity programme in March 2024 (pre-restructuring, including Ice Cream). FY2025 is the continuing-operations figure after the Ice Cream demerger and the 7,500-role productivity programme (c.6,000 roles removed by Q1 2025). The FY2024 year-end figure on a like-for-like basis was not separately verified.
Unilever is one of the world's three largest fast-moving consumer goods groups by revenue, with €50.5bn of continuing turnover in FY2025, brands used by an estimated 3.7 billion people daily and products sold in around 190 countries. Following the December 2025 demerger of Ice Cream and the March 2026 agreement to combine its Foods business with McCormick, Unilever is in the middle of the most radical portfolio reshaping in its history: it is converging on a pure-play Home and Personal Care (HPC) company with pro-forma revenue of roughly €39bn, anchored in Beauty & Wellbeing, Personal Care and Home Care. Its competitive edge rests on 30 Power Brands (78% of turnover), an unmatched emerging-markets footprint (59–60% of turnover), and scale in India and the United States. The investment debate now centres on whether Unilever can sustain volume-led growth of 4–6% and close its valuation gap with US HPC peers.
What the company does
Unilever develops, manufactures, markets and distributes branded consumer goods across four Business Groups. Its own description in the Form 20-F 2025 characterises it as "a global consumer goods business with a strong category focus and differentiated capabilities." The Group organises its commercial activity around its top 24 markets, grouped into eight geographies and accounting for around 85% of turnover; the remaining smaller and mid-sized markets are run under a lean "One Unilever" (1UL) model in which each market manages its own P&L.
Business model
Unilever's model is that of a branded manufacturer: it captures value through brand equity (pricing power and mix), innovation (formulation science, sensorials, formats), scale procurement and manufacturing, and route-to-market reach that extends from global e-commerce platforms and modern trade to millions of small traditional retailers in emerging markets. The value-creation plan disclosed in the Form 20-F 2025 is explicit: absolute profit growth consistent with a top-third total shareholder return (TSR) ambition, driven by volume growth and gross-margin expansion, with roughly 100% cash conversion, around 2x net debt/underlying EBITDA, strong single-A credit ratings, high-teens underlying ROIC, a dividend payout ratio of around 60% and buybacks funded from surplus cash. Management has ruled out transformational M&A in favour of bolt-ons.
Revenue model
| Revenue type | Approximate share | Commentary |
|---|---|---|
| Product sales (branded consumer goods) | ≈ 97–99% | Virtually all turnover is product revenue sold to retailers, distributors, wholesalers and e-commerce platforms |
| Professional/foodservice sales | Embedded in Foods | Unilever Food Solutions (UFS) sells ingredients to restaurants and caterers; exact share not disclosed |
| Direct-to-consumer / subscription | Small, not disclosed | Nutrafol (hair-growth supplements) and some prestige brands operate subscription and DTC models; share not disclosed |
| Services / licensing | Minor | Transitional Services Agreement fees from TMICC (IT, marketing, co-packing, invoicing) recognised in operating profit for up to two years from December 2025; brand licensing not material |
The split above is an analyst characterisation; Unilever does not disclose a product/service/subscription breakdown.
Value chain position, customers and end-markets
Unilever sits in the middle of the value chain: it buys agricultural commodities (palm oil and its derivatives, soybean oil, vegetables, tea, dairy), petrochemical derivatives (surfactants, plastics) and packaging, and sells finished goods to customers. It is increasingly vertically integrating in surfactants, fragrance and some key materials (Home Care), and in-housing production for premium brands such as Liquid I.V. (around half of production in-housed per the Form 20-F 2025).
Customer types include global and national grocery multiples (e.g., Walmart, where Dove x Crumbl is distributed across more than 4,000 stores), drugstore and beauty specialists (Ulta Beauty for Nutrafol and prestige brands), e-commerce platforms (Amazon, quick-commerce in India and China), cash-and-carry and wholesale, millions of small-format traditional retailers in India and Indonesia (served partly through AI-enabled ordering apps), salons and professional channels (K18, Dermalogica), and foodservice operators (UFS). End-markets are hair care, skin care, prestige beauty, vitamins/minerals/supplements (VMS), deodorants, skin cleansing, oral care, fabric cleaning and enhancers, household cleaning and hygiene, cooking aids, condiments and professional foodservice.
Independent characterisation
Unilever is in transition from a diversified food-and-HPC conglomerate to a focused HPC group with a premium and emerging-markets bias. The Ice Cream demerger (December 2025) and the Foods/McCormick combination (expected to close by mid-2027) together remove roughly 40% of the 2024 group revenue base. What remains is a portfolio that is structurally faster-growing (Beauty & Wellbeing and Personal Care grew 4.3% and 4.7% respectively in FY2025) but historically lower-margin in Home Care (14.9% underlying operating margin in FY2025). The strategic logic is coherent and supported by recent execution, but investors should recognise that the post-Foods Unilever will lose its highest-margin Business Group: Foods earned a record 22.6% underlying operating margin in FY2025.
Strategy
Stated strategy (Annual Report 2025 and investor communications)
The strategic framework disclosed in the Form 20-F 2025 rests on a value-creation ambition of absolute profit growth consistent with top-third TSR, driven by volume growth and gross-margin expansion. It is delivered through three fundamental shifts:
-
Desire at Scale (brands): "SASSY" brands built on Science, Aesthetics, Sensorials, being Shared by others and Young-spirited; plus a "frontline machine" for marketing and sales execution across every channel.
-
Play to Win (people): a performance culture with differentiated reward and an uncompromising stance on talent.
-
Fit for the AI Age (organisation): AI and technology deployed across creativity, growth and margin, together with productivity and simplicity.
These are focused on seven strategic growth priorities: Beauty, Wellbeing and Personal Care (categories); Premium (proposition); Digital Commerce (channel); and the United States and India (geographies). Sustainability (climate, nature, plastics, livelihoods) is positioned as an underpinning rather than a headline strategy, a notable shift from the Sustainable Living Plan era.
Strategic initiatives in the last 24 months
| Initiative | Timing | Detail and targets | Status |
|---|---|---|---|
| Productivity programme | Launched March 2024 | €800m savings; c.7,500 roles affected; separation of Ice Cream-related stranded costs | Completed ahead of plan by H1 2026 (€670m achieved by end-2025) |
| Ice Cream demerger | March 2024–December 2025 | TMICC listed 8 December 2025; 19.85% retained, to be sold down within about five years | Completed; TSA runs up to December 2027 |
| Foods combination with McCormick | Announced 31 March 2026 | Reverse Morris Trust; $15.7bn cash; Unilever shareholders 55.1% and Unilever 9.9% of the combined company; ~$600m cost synergies by year three | Expected completion by mid-2027 at the latest |
| Category-dedicated sales forces | 2,025 | Separate Business Group sales organisations in each of the top 24 markets | Implemented |
| Indonesia and China resets | 2,025 | Route-to-market and portfolio changes | Both returned to growth in H2 2025 and grew in H1 2026 |
| Latin America corrective actions | H2 2025 | Price-gap restoration in Brazil Home Care; deodorant format-mix changes | Brazil double-digit growth in Q2 2026 |
| Social-first marketing and AI content studios | 2025–2026 | Beauty AI Studio, Personal Care AI Studio (four markets), Sketch Pro (Home Care), Brand DNAi governance framework; tripling of creator content for Dove US | Scaling in 2026 |
| Fragrance capability | €100m announced 2024 | In-house fragrance design; first in-house Dove fragrance launched in 2025 | Ongoing |
| FIFA World Cup 2026 sponsorship | June–July 2026 | Official Personal Care Sponsor; Rexona official deodorant | Activated; supported Q2 2026 volumes |
| Portfolio pruning | 2025–2026 | 10 transactions closed or announced since start of 2025 | Ongoing |
| Capital returns | 2026–2029 | €6bn total buybacks over 2026–2029 supported by McCormick cash; €1.5bn completed June 2026 | In progress |
Net-zero operational emissions (Scope 1 and 2) by 2030 versus 2015; Scope 3 energy and industrial emissions -42% and FLAG emissions -30.3% by 2030 versus 2021; virgin plastic footprint -30% by 2026 and -40% by 2028 versus 2019; and regenerative agriculture on 1m hectares by 2030. Unilever will review the scope and baselines of these goals in 2026 after the Ice Cream demerger.
Medium-term guidance
| Metric | Guidance |
|---|---|
| Underlying sales growth | Multi-year range of 4% to 6% |
| Underlying volume growth | At least 2% (FY2026 upgraded to around 3%) |
| Underlying operating margin | Modest improvement annually, fuelled by gross margin |
| Cash conversion | Around 100% over time |
| Leverage | Around 2x net debt / underlying EBITDA; strong single-A ratings |
| ROIC | High teens |
| Dividend payout | Around 60% of underlying EPS |
| M&A | Bolt-on only; no transformational M&A |
Products & Services
Unilever does not disclose brand-level revenue, launch-year data for most lines, or pricing. The catalog below is organised brand by brand from the Form 20-F 2025 and FY2025/H1 2026 results; launch years are given only where disclosed.
Beauty & Wellbeing
| Brand | Category | Description and flagship offerings | Target customer | Latest disclosed innovation / year | Pricing model |
|---|---|---|---|---|---|
| Dove (hair and skin) | Hair Care / Skin Care | Mass-premium hair and skin care; renovated hair range using Bio-Protein Care / fibre-repair technology rolled out across eight markets including US, India and Brazil | Mass and masstige consumers globally | Renovated hair care range, 2025 | Retail, mass-premium |
| Sunsilk | Hair Care | Mass hair care strong in emerging markets; double-digit growth in Q2 2026 | Emerging-market mass consumers | — | Mass retail, sachets |
| Clear | Hair Care | Anti-dandruff scalp-care brand | Emerging markets, men and women | — | Mass retail |
| TRESemmé | Hair Care | Salon-inspired mass hair care; improving in US in H1 2026 | Mass consumers | — | Mass retail |
| Nexxus | Hair Care | Salon-quality premium hair care | Premium US consumers | — | Premium retail |
| K18 | Prestige hair | Biotech peptide-based hair repair; HeatBounce leave-in heat protectant | Prestige and salon consumers | HeatBounce, 2025 (acquired 2024) | Prestige, salon and retail |
| Vaseline | Skin Care | Petroleum-jelly-based skin protection, lotions; double-digit growth for three consecutive years; #VaselineVerified social campaign (Cannes Titanium Lion) | Mass global | Premium innovations 2025–2026 | Mass retail |
| Pond's | Skin Care | Facial skin care, strong in Asia | Mass/masstige Asia | — | Mass retail |
| Dermalogica | Prestige Skin Care | Professional skin care sold through skin therapists and retail | Professional and prestige | Returned to growth H2 2025 | Prestige, professional |
| Paula's Choice | Prestige Skin Care | Actives-led skin care, DTC heavy | Ingredient-savvy consumers | Strong Q2 2026 | Prestige, DTC |
| Hourglass | Prestige Cosmetics | Luxury colour cosmetics | Prestige | Strong double-digit growth 2025 | Prestige |
| Tatcha | Prestige Skin Care | Japanese-inspired luxury skin care | Prestige | Strong Q2 2026 | Prestige |
| Minimalist (via HUL) | Skin Care (India) | Premium, actives-led beauty brand; 90.5% acquired April 2025 | Urban Indian consumers | Acquired 2025 | Digital-first, premium |
| Nutrafol | Wellbeing (VMS) | Hair-growth supplements; number-one dermatologist-recommended hair-growth supplement in US; turnover tripled since 2022 acquisition; Ulta Beauty retail expansion and MLB partnership; positioning as a complement to GLP-1 regimens | Consumers with hair thinning | Ulta expansion, 2025 | Subscription/DTC and retail |
| Liquid I.V. | Wellbeing (VMS) | Electrolyte hydration multiplier; sugar-free range (first launched US 2023) extended to three markets including China; launch in India; sugar-free energy line | Active, health-conscious consumers | India launch, energy line 2025 | Retail and e-commerce |
| OLLY | Wellbeing (VMS) | Gummy vitamins and supplements; premium gummy innovation | Mass-premium US consumers | Premium gummies 2025 | Retail |
| Grüns | Wellbeing (VMS) | US greens supplement leader; acquired June 2026 | Health-conscious US consumers | Acquired 2026 | DTC / subscription (company characterisation not disclosed) |
| REN | Prestige Skin Care | Closure announced 2025 (€42m impairment) | — | Discontinued | — |
| Kate Somerville | Prestige Skin Care | Divested November 2025 | — | Divested | — |
Personal Care
| Brand | Category | Description and flagship offerings | Target customer | Latest disclosed innovation / year | Pricing model |
|---|---|---|---|---|---|
| Dove / Dove Men+Care | Skin Cleansing, Deodorants | Serum Shower Collection with MicroMoisture technology (launched 2024 in North America, India late 2025); Whole Body Deodorant (US launch 2024); Dove x Crumbl limited editions; first in-house fragrance (Garden Tea Party) | Mass-premium global | Serum Body Wash; Whole Body Deo; 2024–2025 | Mass-premium retail |
| Rexona / Degree / Sure | Deodorants | Antiperspirants; Whole Body formats; official deodorant sponsor of FIFA World Cup 2026; "The Locker Room" social hub | Mass, sports-oriented | FIFA 2026 activations | Mass retail |
| Axe / Lynx | Deodorants, Body Wash | Fragrance-led male grooming; gourmand variants (Cherry Spritz, Sunset Fresh) | Gen Z males | 2025 limited editions | Mass retail |
| Lux | Skin Cleansing | Fragrance-led beauty soap and body wash; new fragrance range in China | Mass Asia | 2,026 | Mass retail |
| Lifebuoy | Skin Cleansing | Germ-protection soap and hand wash; flat in 2025 due to commodity-led price rises | Mass emerging markets | — | Mass retail |
| Closeup | Oral Care | Toothpaste; Closeup White Now whitening using stain-control science across Asia | Young consumers in Asia | 2,025 | Mass retail |
| Pepsodent | Oral Care | Toothpaste; premium naturals and whitening ranges | Mass Asia | 2,025 | Mass retail |
| Signal | Oral Care | European/Latin toothpaste brand (not a Power Brand) | Mass | — | Mass retail |
| Dr. Squatch | Personal Care (men's natural) | Natural soap, deodorant and grooming; 98.7% acquired September 2025 for €1,243m | US millennial/Gen Z men | Acquired 2025 | DTC and retail |
| Wild | Personal Care (natural, refillable) | Refillable deodorants, lip balm, body and hand wash; 100% acquired April 2025 | Sustainability-minded consumers | Acquired 2025 | DTC subscription and retail |
Home Care
| Brand | Category | Description and flagship offerings | Target customer | Latest disclosed innovation / year | Pricing model |
|---|---|---|---|---|---|
| Dirt Is Good (Persil, OMO, Skip, Surf Excel, Breeze) | Fabric Cleaning | Laundry powders, liquids and capsules; Wonder Wash for short, cold cycles (launched 2024), now in 30 markets including India and Brazil | Mass and premium households | Wonder Wash 2024–2026 | Mass retail |
| Surf | Fabric Cleaning | Value-tier laundry brand | Value-seeking households | — | Mass retail |
| Brilhante (Brazil) | Fabric Cleaning | Brazilian laundry brand | Brazilian households | — | Mass retail |
| Comfort / Fofo | Fabric Enhancers | Fabric conditioners, boosters; premium formats and fragrance-led innovation | Mass/premium | Boosters 2025 | Mass retail |
| Cif | Home & Hygiene | Surface cleaners; Cif Infinite Clean probiotic multi-purpose spray with 72-hour action (launched 2025, five European markets); reusable trigger spray (UK) | Households in Europe, LatAm, Asia | 2,025 | Mass-premium retail |
| Domestos | Home & Hygiene | Toilet and bleach-based hygiene | Mass global | Premium innovations 2025 | Mass retail |
| Sunlight | Dishwash / Laundry | Dishwash and laundry bars and liquids; probiotic tech in Vietnam | Mass emerging markets | — | Mass retail |
| Radiant | Fabric Cleaning | Laundry brand (primarily Asia) | Mass Asia | — | Mass retail |
| Vim | Home & Hygiene | Dishwash; extended into adjacent cleaning in India; probiotic variants | Indian households | — | Mass retail |
| Wipol | Home & Hygiene | Indonesian floor/surface cleaner with probiotic technology | Indonesian households | — | Mass retail |
Foods (to be combined with McCormick, excluding India and certain other territories)
| Brand / offering | Category | Description and flagship offerings | Target customer | Latest disclosed innovation / year | Pricing model |
|---|---|---|---|---|---|
| Knorr | Cooking Aids & Mini Meals | Bouillons, seasonings, soups, ready-to-heat pots, air-fryer cooking pastes (UK, Germany) | Home cooks globally | Air-fryer pastes, 2025 | Mass retail |
| Hellmann's / Best Foods | Condiments | Mayonnaise and flavoured mayo (range reached €100m across 35 markets), squeeze formats in Brazil; US competition in premium and avocado mayo | Households | Flavoured mayo; 2025 | Mass retail |
| Horlicks (via HUL) | Health Food Drinks | Malted health drink, double-digit growth in India H1 2026; remains with Unilever (India excluded from the McCormick perimeter) | Indian families | 2026 innovation | Mass retail |
| Unilever Food Solutions | Professional foodservice | Knorr Professional (incl. Seasoned Soy Sauce, China), Hellmann's foodservice; Future Menus programme with chefs in 50+ markets; largest markets China and US | Restaurants, caterers | 2,025 | B2B distribution |
| Colman's, Marmite, Pfanni, Mondamin, Unox, Zwan | Local foods brands | Local heritage brands; binding offers received for Unox and Zwan (2025) | Local markets | — | Mass retail |
| Divested since 2025 | — | Conimex (to Paulig, April 2025), The Vegetarian Butcher (September 2025), Graze (February 2026), Indonesia tea/Sariwangi (March 2026) | — | — | — |
Brand-level pricing is not publicly disclosed for any Unilever brand.
Financial Narrative
Headline P&L — as originally reported (FY2021–FY2024 include Ice Cream; FY2025 is continuing operations unless labelled)
Notes and sources: Turnover and attributable net profit from Unilever FY results as compiled by MarketScreener and confirmed against company releases for FY2023–FY2025. FY2025 total net profit and attributable profit include the €3,373m tax-exempt gain on the Ice Cream demerger; FY2025 net profit from continuing operations was €6,213m (€5,682m attributable). FY2025 diluted EPS is the continuing-operations figure after the 8-for-9 consolidation; total-operations diluted EPS was €4.32. FY2024 total net profit (€6,369m) is as re-stated in the FY2025 accounts and is consistent with the €6.4bn originally reported. Underlying EBITDA for FY2021–FY2024 is from MarketScreener (company-based); FY2025 is per the FY2025 Results. Free cash flow: FY2021 and FY2024 rounded from company disclosures (€6.4bn; €6.9bn as originally reported, €6.3bn continuing); FY2022 (€5.2bn) and FY2023 (€7.1bn) per the FY2023 Results. Net debt FY2021–FY2023 from aggregator data consistent with company definitions; MarketScreener reports different values (FY2021 25510; FY2022 23676; FY2023 23657) — discrepancy noted; primary filings should be consulted. Dividends: quarterly declarations of €0.4268 through Q1 2024, €0.4396 for Q2–Q3 2024, €0.4528 for Q4 2024–Q3 2025 and €0.4664 from Q4 2025 (company dividend history).
Continuing-operations P&L (re-presented)
Gross profit is derived as gross margin × turnover. FY2024 gross margin is inferred from the 20bps improvement reported for FY2025. Source: FY2025 Results, Form 20-F 2025.
Revenue CAGR. On an as-reported basis turnover fell from €52.4bn (FY2021) to €50.5bn (FY2025), a CAGR of about -0.9%, but this is distorted by the removal of Ice Cream (≈€7.7–8.3bn a year), the tea disposal and currency. A more meaningful indicator is cumulative underlying sales growth: compounding the reported USG of 4.5%, 9.0%, 7.0%, 4.2% and 3.5% gives about 31% over five years, overwhelmingly price-led in 2022–2023 and volume-led since 2024. Currency translation was severely adverse (-5.9% in FY2025 alone, driven by Latin American currencies, the Indian rupee, the US dollar and the Turkish lira).
Commentary. The five-year record divides into two phases. In 2021–2023, Unilever navigated a commodity super-cycle by pricing aggressively (UPG of 6.8% in FY2023 on the original basis), which protected revenue but crushed volumes (0.2% in FY2023) and compressed margins: underlying operating margin fell from 18.4% (FY2021) to 16.7% (FY2022, originally reported). From late 2023, under the Growth Action Plan and then the Fernandez agenda, the model inflected towards volume growth, gross-margin rebuild (continuing gross margin 46.9% in FY2025) and a step-up in brand investment (BMI up roughly 300bps over four to five years to 16.1%). Underlying operating margin reached a record 20.0% in FY2025 on a continuing basis, helped by the removal of lower-margin Ice Cream and €670m of productivity savings. The key weakness is that reported profit and EPS growth have been neutralised by currency: underlying EPS rose only 0.7% in FY2025 despite constant-currency profit growth, with an 8.8% adverse currency effect.
Balance sheet
The FY2025 decline in goodwill, PP&E and equity reflects the Ice Cream demerger: carrying net assets of €4.0bn were derecognised and a non-cash dividend of €6,752m was recorded against retained earnings. The retained 19.85% stake in TMICC was carried at €1,655m (fair value through OCI) at 31 December 2025. Source: FY2025 Results; 2026 First Half Results.
Cash flow
FY2025 cash conversion was 100% (FY2024: 104%). FY2025 FCF fell €0.4bn mainly due to tax on disposals linked to the Ice Cream demerger. Unilever expects around 100% cash conversion again in FY2026.
Key ratios
Calculations: FY2025 ROE uses continuing attributable profit (€5,682m) to exclude the demerger gain; FY2024 uses total attributable profit (€5,744m). FY2024 net debt/EBITDA uses the continuing UEBITDA; Unilever originally reported 1.9x including Ice Cream. FY2024 asset turnover mixes a continuing turnover figure with balance-sheet assets that still included Ice Cream, and is therefore understated. At H1 2026 net debt/underlying EBITDA rose to 2.3x (rolling twelve months), driven by dividends and the €1.5bn buyback; management guides to around 2x for FY2026.
Cash conversion cycle: not publicly disclosed. A derived calculation is not meaningful because the FY2025 receivables and payables are grossed up by the TMICC transitional services arrangement and "trade payables and other current liabilities" includes non-trade items. Indicatively, inventory days were about 55 on FY2025 derived cost of sales.
Trend commentary. Returns are high and stable (underlying ROIC around 19%) because Unilever operates with structurally negative working capital and a large base of acquired intangibles. Liquidity ratios below 1.0x are typical for large FMCG companies with strong supplier financing and are not a concern given $5.2bn and €2.6bn of undrawn 364-day facilities, plus a further €2.0bn signed in June 2026. Leverage is at the top of the "around 2x" target range; the $15.7bn cash from McCormick (≈€13.7bn) is earmarked for separation costs, debt reduction and €6bn of buybacks over 2026–2029.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Turnover (EUR Mn) | 52,444 | 60,073 | 59,604 | 60,761 | 50,503 |
Underlying sales growth (%) | 4.5 | 9.0 | 7.0 | 4.2 | 3.5 |
Underlying EBITDA (EUR Mn) | 11,382 | 11,408 | 11,510 | 12,803 | 11,394 |
Total net profit incl. discontinued (EUR Mn) | 6,621 | 8,269 | 7,137 | 6,369 | 10,011 |
Net profit attributable to shareholders (EUR Mn) | 6,049 | 7,642 | 6,487 | 5,744 | 9,469 |
Diluted EPS as reported (EUR) | 2.33 | 2.98 | 2.56 | 2.29 | 2.59 |
Dividends declared per share (EUR) | 1.7072 | 1.7072 | 1.7072 | 1.7588 | 1.8248 |
Free cash flow (EUR Mn) | 6,400 | 5,200 | 7,100 | 6,900 | 5,921 |
Net debt (EUR Mn) | 26,257 | 24,113 | 24,434 | 24,519 | 23,076 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansCash Flow and Margin Analysis (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Turnover (EUR Mn) | 51,700 | 52,479 | 50,503 |
Underlying volume growth (%) | 1.1 | 3.1 | 1.5 |
Underlying price growth (%) | 6.5 | 1.2 | 2.0 |
Underlying operating margin (%) | 17.6 | 19.4 | 20.0 |
Operating margin (%) | 17.4 | 16.8 | 17.9 |
Cash flow from operating activities (EUR Mn) | 10,300 | 10,913 | 10,772 |
Free cash flow (EUR Mn) | 6,400 | 6,304 | 5,921 |
Margin Analysis (%) and Income Statement
| Metric | FY2024 | FY2025 |
|---|---|---|
Gross margin (%) | 46.7 | 46.9 |
Gross profit — derived (EUR Mn) | 24,508 | 23,686 |
Brand & marketing investment (% of turnover) | 16.0 | 16.1 |
Underlying operating profit (EUR Mn) | 10,198 | 10,084 |
Operating profit (EUR Mn) | 8,829 | 9,037 |
EBITDA reported (EUR Mn) | 10,065 | 10,347 |
Underlying EBITDA (EUR Mn) | 11,434 | 11,394 |
Profit before tax (EUR Mn) | 8,371 | 8,693 |
Net profit, continuing (EUR Mn) | 6,039 | 6,213 |
Net profit attributable, continuing (EUR Mn) | 5,430 | 5,682 |
Diluted EPS continuing, consolidation-adjusted (EUR) | 2.44 | 2.59 |
Underlying EPS diluted (EUR) | 3.06 | 3.08 |
Underlying effective tax rate (%) | 25.9 | 25.7 |
Net margin, continuing (%) | 11.5 | 12.3 |
Underlying EBITDA margin (%) | 21.8 | 22.6 |
Balance Sheet
| Metric (EUR Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Total assets | 75,266 | 79,750 | 70,471 |
Total equity | 20,764 | 22,555 | 17,587 |
Net debt | 24,434 | 24,519 | 23,076 |
Balance Sheet (FY2024–H1 2026)
| Metric (EUR Mn) | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|
Cash and cash equivalents | 6,136 | 3,941 | 4,726 |
Current financial liabilities (short-term debt) | 6,987 | 2,582 | 8,142 |
Non-current financial liabilities (long-term debt) | 25,066 | 25,696 | 23,968 |
Total financial liabilities | 32,053 | 28,278 | 32,110 |
Net debt | 24,519 | 23,076 | 25,961 |
Goodwill | 22,311 | 17,709 | 18,515 |
Intangible assets | 18,590 | 17,055 | 17,560 |
Goodwill and intangibles | 40,901 | 34,764 | 36,075 |
Current assets | 19,194 | 17,066 | 21,389 |
Current liabilities | 25,234 | 21,662 | 28,891 |
Working capital (current assets less current liabilities) | -6,040 | -4,596 | -7,502 |
Shareholders' equity | 19,990 | 15,530 | 16,194 |
Pension surplus, net | 3,000 | 3,500 | 3,700 |
Cash Flow
| Metric (EUR Mn) | FY2024 | FY2025 | H1 2025 | H1 2026 |
|---|---|---|---|---|
Cash flow from operating activities (pre-tax, continuing) | 10,913 | 10,772 | 3,147 | 4,347 |
Income tax paid | 2,452 | 2,720 | 1,128 | 1,770 |
Net capital expenditure | 1,599 | 1,465 | 480 | 599 |
Net interest paid | 559 | 666 | 455 | 429 |
Free cash flow | 6,304 | 5,921 | 1,084 | 1,549 |
Dividends paid on ordinary capital | 4,319 | 4,453 | 2,234 | 2,033 |
Share repurchases | 1,508 | 1,510 | 1,510 | 1,507 |
Acquisitions of businesses (cash) | 734 | 1,674 | 458 | 867 |
Disposals of businesses (cash) | 910 | 107 | 73 | 206 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2024 | FY2025 |
|---|---|---|
ROE — attributable net profit / average shareholders' equity (%) | 30.2 | 32.0 |
ROA — net profit / average total assets (%) | 8.2 | 8.3 |
Underlying ROIC (company, %) | 19.1 | 19.0 |
Current ratio (x) | 0.76 | 0.79 |
Total financial liabilities / total equity (x) | 1.42 | 1.61 |
Net debt / underlying EBITDA (x) | 2.14 | 2.03 |
Interest coverage — operating profit / finance costs (x) | 8.9 | 8.8 |
Interest coverage — UOP / net finance costs (x) | 19.6 | 20.0 |
Asset turnover — turnover / average total assets (x) | 0.68 | 0.67 |
Revenue by Region
| Region (turnover, EUR Mn) | FY2024 | FY2025 |
|---|---|---|
Asia Pacific Africa | 23,448 | 22,427 |
The Americas | 19,605 | 18,622 |
Europe | 9,426 | 9,454 |
Total | 52,479 | 50,503 |
Region (FY2025) Overview
| Region (FY2025) | Turnover change % | USG % | UVG % | UPG % | Currency % | % of group |
|---|---|---|---|---|---|---|
Asia Pacific Africa | -4.4 | 4.6 | 3.0 | 1.6 | -6.5 | 44 |
The Americas | -5.0 | 3.3 | 0.0 | 3.2 | -7.8 | 37 |
Europe | 0.3 | 1.5 | 1.2 | 0.3 | -0.1 | 19 |
Revenue by Region (FY2025–H1 2026)
| Cluster (turnover, EUR Mn) | FY2025 | H1 2026 |
|---|---|---|
Emerging markets | 30,000 | 15,400 |
Developed markets | 20,500 | 10,200 |
North America | 11,200 | 5,700 |
Latin America | 7,400 | 4,000 |
Revenue by Region (%)
| Cluster (USG %) | FY2025 | H1 2026 |
|---|---|---|
Emerging markets | 3.5 | 7.0 |
Developed markets | 3.6 | 1.5 |
North America | 5.3 | 2.7 |
Latin America | 0.5 | 7.6 |
Asia Pacific Africa | 4.6 | 7.3 |
Europe | 1.5 | -0.9 |
Valuation Snapshot
| Metric | Value |
|---|---|
Price, 25 Sep 2026 (LSE, pence) | 4,664.5 |
2026 opening price (pence) | 4,851.5 |
2026 YTD change (%) | -3.85 |
2026 high (pence) | 5,526 |
2026 low (pence, as reported by aggregator; may reflect a data anomaly) | 3,644 |
TSR over two years to end-2025 (%, company) | 26.8 |
Peer average TSR over same period (%, company) | -8 |
Share price change since demerger to 2 March 2026 (%, company) | 11.6 |
Valuation Multiples
| Multiple | Unilever | Basis |
|---|---|---|
P/E on FY2025 underlying EPS (€3.08) | ≈ 17.4x | Price ≈ €53.7 |
P/E on FY2025 diluted continuing EPS (€2.59) | ≈ 20.7x | — |
EV/underlying EBITDA FY2025 | ≈ 12.4x | Market cap ≈ €115bn + net debt €26.0bn (H1 2026) |
EV/Sales FY2025 | ≈ 2.8x | — |
P/B | ≈ 7.1x | Shareholders' equity €16.2bn (H1 2026) |
Source Details
| Source | Rating / target | Date |
|---|---|---|
eToro average price target | 4,300p–4,600p (varied across pages) | 2026 |
Simply Wall St consensus target | £52.14 (range £40.87–£60.52 across snapshots) | 2026 |
UBS (Guillaume Delmas) | Sell; 4,440p | 20 Mar 2026 |
Berenberg | Downgraded to Hold; target raised to 5,840p | 18 Feb 2026 |
Unilever-compiled consensus for FY2026 (pre-Q1) | USG 4.0%, UVG 2.1%, UOM 20.1%, EPS growth 3.4% | Q1 2026 |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends declared per share (EUR) | 1.7072 | 1.7072 | 1.7072 | 1.7588 | 1.8248 |
Dividends paid on ordinary capital (EUR Mn) | — | — | — | 4,319 | 4,453 |
Capital Programmes
| Programme | Size | Executed | Shares repurchased |
|---|---|---|---|
| 2,024 | €1.5bn | 2,024 | Not compiled |
| 2,025 | €1.5bn | 13 Feb–30 May 2025 | 27,815,955 |
| 2,026 | €1.5bn | 30 Apr–5 Jun 2026 | 30,703,780 |
2026–2029 plan | €6.0bn total (incl. 2026 programme) | Ongoing | — |
Credit Ratings
| Agency | Long-term | Short-term | Outlook |
|---|---|---|---|
S&P | A+ | A-1 | Negative |
Moody's | A1 | P-1 | Stable |
Morningstar DBRS | — | — | Stable |
Maturity Year Details
| Maturity year | Notable instruments disclosed (selection) |
|---|---|
| 2026 | 2.0% and 7.25% US notes; €500m 0.75% note repaid February 2026 |
| 2027 | 2.9% and 4.25% notes; €600m floating-rate notes (September 2027) |
| 2028 | 3.5%, 4.875% and 6.625% notes |
| 2029 | 2.125% notes |
| 2030 | 1.375% notes; €700m 2.75% (May 2030) |
| 2031 | 4.75% and 1.75% notes |
| 2032 | 5.9% notes; €850m 2.875% (October 2032) |
2033–2035 | 5.0% (2033), 4.625% (2034), $150m 4.824% and €800m 3.375% (2035) |
| 2037 | €800m 3.50% (October 2037) |
2051 and 2097 | 2.625% (2051); 5.600% (2097) |
Analyst Conclusions
Management guidance (upgraded 28 July 2026)
| Metric | FY2026 guidance |
|---|---|
| Underlying sales growth | Within 4%–6% multi-year range (previously bottom end) |
| Underlying volume growth | Around 3% (previously at least 2%) |
| H2 2026 USG | 4%–5%, led by pricing |
| Underlying operating margin | Modest improvement versus 20.0% |
| H2 gross margin | Broadly similar to H1 (46.8%) |
| Restructuring | About 1.0% of turnover |
| Underlying effective tax rate | Around 26% |
| Net finance costs | Below 3% of average net debt |
| Cash conversion | Around 100% |
| Net debt / underlying EBITDA | Around 2x by year-end |
Consensus growth expectations
Pre-Q1 company-compiled consensus expected FY2026 USG of 4.0%, UOM of 20.1% and EPS growth of 3.4%. MarketScreener's aggregated forecasts show turnover of about €51.8bn (FY2026) rising to about €55.5bn (FY2028), with net debt drifting towards €22bn by FY2028.
Bull case
-
Volume inflection is real and broad-based. Q2 2026 volume growth of 5.5%, with all four Business Groups growing volume and emerging markets at +7.4% volume, suggests improved execution rather than an easy comparison.
-
Pure-play HPC plus buybacks equals a re-rating. Post-McCormick, Unilever becomes a roughly €39bn HPC company with the Foods cash funding €6bn of buybacks over 2026–2029; at about 17x underlying earnings, the shares trade at a discount to many US HPC peers.
-
Margin structure keeps improving. The €800m productivity programme is complete, overheads improved 70bps in H1 2026 and BMI is already at a competitive 16.1%, leaving gross-margin and mix gains to flow through.
Bear case
-
Pricing-led H2 and commodity squeeze. H2 2026 growth is guided to be led by price as commodity costs rise; gross margin already fell 70bps in H1, and volumes could soften as prices land.
-
Loss of the best-margin business. Foods earned a 22.6–23.3% underlying operating margin; removing it mechanically dilutes group margin and earnings (UBS flagged dilution), and Unilever's residual 9.9% stake carries market risk.
-
Developed-market and Wellbeing deceleration. North America slowed to 2.7% USG in H1 2026, Europe is declining and Wellbeing has moderated, which matters because the US is a designated anchor geography and prestige/Wellbeing are the premium growth engines.
Catalysts and monitorables (next 12 months)
| Date / window | Catalyst | What to monitor |
|---|---|---|
| 28 Oct 2026 | Q3 2026 trading statement | Price/volume balance as pricing lands; Brazil Vinhedo impact; Foods recovery |
| 4 Nov 2026 | Investor Event, New York | Pure-play HPC targets, US strategy, possible updated medium-term framework |
| Q4 2026 | Brazil tax reform | Retailer destocking ahead of 2027 price reductions |
| H1 2027 | McCormick shareholder vote; antitrust and works-council processes | Timing, any remedies, final cash adjustments |
| By mid-2027 | Foods completion | Re-presentation of Foods as discontinued; use of $15.7bn cash |
| Ongoing | TMICC stake selldown | Proceeds and timing of the 19.85% stake disposal |
| Feb 2027 | FY2026 results | Delivery against upgraded guidance; 2027 outlook; buyback size |
| Ongoing | Leverage and ratings | S&P negative outlook resolution |
Analyst verdict
Unilever in late 2026 is a markedly better-run company than the one that drifted through 2019–2023. The evidence is no longer anecdotal: twelve-plus consecutive quarters of positive volume, a record 20% underlying operating margin on a continuing basis, the productivity programme delivered ahead of plan, and an upgraded FY2026 outlook built on the best volume quarter in more than a decade. Management has also shown it can execute complex portfolio surgery, completing the Ice Cream demerger on schedule and agreeing a tax-efficient Reverse Morris Trust for Foods within a year of taking office.
The strategic destination — a focused Beauty, Wellbeing, Personal Care and Home Care company anchored in the US and India, with 60% emerging-market exposure — is the right one, and it is the configuration most likely to narrow the valuation gap with US HPC peers. The cash from McCormick provides unusual flexibility: debt reduction, €6bn of buybacks and room for bolt-ons such as Dr. Squatch and Grüns.
Three issues temper the enthusiasm. First, the post-Foods company will be structurally lower-margin, with Home Care still below 16% and dependent on petrochemical inputs at a time of commodity inflation. Second, reported earnings remain hostage to emerging-market currencies, which have consumed almost all constant-currency EPS growth in recent years. Third, the next twelve months are execution-dense: a pricing-led second half, Brazilian regulatory and tax disruption, the TMICC services agreement, the Foods carve-out and an investor day that must set credible pure-play targets.
On balance, the investment case is improving but not yet de-risked. Unilever merits a constructive-but-selective stance: the volume-led recovery and capital-return programme support upside, while the key monitorables are H2 price-volume balance, North American Wellbeing trends and on-time, on-terms completion of the McCormick combination. Delivery on those three points would likely be the trigger for a sustained re-rating.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / background (as disclosed) |
|---|---|---|
Fernando Fernandez | Chief Executive Officer, Executive Director | CEO since 1 March 2025; CFO January 2024–February 2025; previously President Beauty & Wellbeing, head of Latin America, Unilever Brazil (2011–2019), Unilever Philippines, Global Hair Care. Age reported as 59 (Simply Wall St) |
Srinivas Phatak | Chief Financial Officer, Executive Director | Acting CFO from March 2025; the 2025 Directors' Remuneration Report covers his Executive Director period from 16 September 2025; previously in senior finance leadership at Hindustan Unilever |
Eduardo Campanella | Business Group President, Home Care | President Home Care since late 2023; previously Chief Marketing Officer Home Care |
Fabian Garcia | Business Group President, Personal Care | In role since the 2022 Business Group model |
Heiko Schipper | Business Group President, Foods | Leads Foods through the McCormick separation |
Reginaldo Ecclissato | President, 1 Unilever Markets | Leads the One Unilever cluster of small and mid-sized markets |
Priya Nair | CEO & Managing Director, Hindustan Unilever | CEO of HUL since 1 August 2025 (five-year term); first woman to lead HUL; previously President Beauty & Wellbeing (2023–2025); joined HUL in 1995 |
Prakash Kakkad | Chief Legal Officer and Group Company Secretary | Succeeded Maria Varsellona |
Mairéad Nayager | Chief People Officer | Leads the "Play to Win" people strategy |
Richard Slater | Chief Research & Development Officer | Leads global R&D |
Willem Uijen | Chief Supply Chain and Operations Officer | Leads the supply chain |
Board of Directors
| Name | Role | Background (summary) |
|---|---|---|
Ian Meakins | Chair, Non-Executive Director | Chair by 2024; former CEO of Wolseley/Ferguson; extensive FTSE chair experience |
Susan Kilsby | Vice Chair, Senior Independent Director, Chair of the Remuneration Committee | Took both roles at the 2025 AGM; former chair of Shire |
Fernando Fernandez | CEO, Executive Director | See above |
Srinivas Phatak | CFO, Executive Director | See above |
Adrian Hennah | Independent Non-Executive Director | Former CFO of Reckitt Benckiser |
Ruby Lu | Independent Non-Executive Director | Venture-capital investor (Asia, technology/consumer) |
Judith McKenna | Independent Non-Executive Director | Former President and CEO, Walmart International |
Nelson Peltz | Non-Executive Director | Founding Partner and CEO of Trian Fund Management; joined in 2022 |
Benoît Potier | Independent Non-Executive Director | Former Chairman and CEO of Air Liquide; joined 2025 |
Zoe Yujnovich | Independent Non-Executive Director | Former senior executive at Shell; joined 2025 |
Directors' Remuneration
| Item | Fernando Fernandez | Srinivas Phatak |
|---|---|---|
Fixed pay paid in 2025 (EUR) | 1,710,521 | 342,708 |
Annual fixed pay rate as CEO (EUR) | 1,800,000 | — |
Bonus deferred into shares (EUR) | 464,237 | 76,287 |
2025 single figure of total remuneration (EUR) | ≈ 5.6m (third-party compilation; verify against DRR p.96) | — |
Board & Management Changes
| Date | Change |
|---|---|
25 February 2025 | Hein Schumacher to step down; Fernando Fernandez named CEO effective 1 March 2025; Srinivas Phatak named acting CFO |
April 2025 | Benoît Potier and Zoe Yujnovich elected to the Board; Susan Kilsby becomes Vice Chair and SID |
10 July 2025 | Priya Nair named HUL CEO & MD effective 1 August 2025, succeeding Rohit Jawa |
September 2025 | Srinivas Phatak formally joins the Board as CFO |
1 January 2026 | At HUL, Vandana Suri becomes Executive Director Home Care; Srinandan Sundaram becomes CEO of Unilever International |
July 2026 | Belén Garijo López withdraws from planned NED appointment |
Competitive Landscape
Competitors by Segment
| Segment | Principal competitors |
|---|---|
Beauty & Wellbeing | L'Oréal, Procter & Gamble, Estée Lauder, Beiersdorf, Kenvue, Shiseido, Kao, Haleon (VMS), Church & Dwight (VMS), Bayer consumer health |
Personal Care | Procter & Gamble, Colgate-Palmolive, Beiersdorf, Henkel, Edgewell, Church & Dwight, Kenvue, Haleon (oral care) |
Home Care | Procter & Gamble, Henkel, Reckitt, Colgate-Palmolive, Clorox, Kao, strong local players (e.g., Nirma in India; Ypê in Brazil) |
Foods | Nestlé, Kraft Heinz, McCormick (future partner), Ajinomoto, Mars Food, Campbell's, Lee Kum Kee, local condiment makers |
Peer Comparison FY2025
| Company | Latest FY revenue (approx.) | Organic growth (approx.) | Margin (approx.) | R&D intensity |
|---|---|---|---|---|
Unilever (FY2025, continuing) | €50.5bn | 3.5% USG | 20.0% UOM | 1.7% |
Procter & Gamble (FY to June 2025) | ≈ $84bn | ≈ 2% organic | ≈ 24% operating margin | — |
L'Oréal (FY2024) | ≈ €43.5bn | ≈ 5% like-for-like | ≈ 20% operating margin | — |
Colgate-Palmolive (FY2024) | ≈ $20bn | ≈ 8% organic | — | — |
Nestlé (FY2024) | ≈ CHF 91bn | ≈ 2% organic | ≈ 17% UTOP margin | — |
Henkel (FY2024) | ≈ €21.6bn | ≈ 2.6% organic | ≈ 14% adjusted EBIT | — |
Reckitt (FY2024) | ≈ £14.2bn | ≈ 1.4% like-for-like | — | — |
Beiersdorf (FY2024) | ≈ €9.9bn | ≈ 6.5% organic | — | — |
Kenvue (FY2024) | ≈ $15.5bn | — | — | — |
McCormick (FY2025) | ≈ $7bn (company description) | — | — | — |



